Global Radiopharmaceuticals Market Is Expected to Reach USD 12.2 Billion in 2018: Transparency Market Research PR Newswire ALBANY, New York, February 20, 2013 ALBANY, New York, February 20, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research ( http://www.transparencymarketresearch.com ), " Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018, " the global market for radiopharmaceuticals was valued at approximately USD 3.8 billion in 2011 and is expected to reach USD 12.2 billion by 2018 at a CAGR of 18.3% from 2012 to 2018. North America led the global radiopharmaceuticals market with the highest market share as Canada continues to be the largest exporter of uranium and nuclear technology, forming the backbone of nuclear medicine and imaging studies. Browse the full report at http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html The market is expected to grow at a CAGR of 18.3% owing to tremendous research and technological developments occurring worldwide and the increasing awareness about nuclear medicine and molecular imaging procedures. The radiopharmaceuticals market is studied based on end-user groups, medical isotopes, applications and geography. Technetium (Tc-99m) is the most widely used radioisotope for medical applications. The majority of the application market for radiopharmaceuticals is constituted by the diagnosis market, and the therapeutic application segment is expected to grow at the fastest growth rate from 2012 to 2018. Related & Recently Published Reports by Transparency Market Research http://www.transparencymarketresearch.com/healthcare-cloud-computing.html http://www.transparencymarketresearch.com/hcro-market.html http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html The global market for generators for radiopharmaceuticals was valued at over USD 200 million in 2011 and is expected to grow at a healthy CAGR from 2012 to 2018. The market currently consists only of Tc-99m generators; newer generators for molecules like Rubidium (Rb-82), Gallium (Ga-67) and Yttrium (Y-90) are expected to enter the market in the next few years. These are expected to exhibit high double digit growth rates during the forecast period. Key players in this market include Covidien Plc, Nordion Inc., Lantheus Medical Imaging and IBA Group, among others. The market is highly fragmented with leading global healthcare companies offering a wide range of diagnostic and therapeutic radiopharmaceuticals. Related & Recently Published Reports by Transparency Market Research http://www.transparencymarketresearch.com/insulin-market.html http://www.transparencymarketresearch.com/us-vaccine-market.html http://www.transparencymarketresearch.com/synthetic-biology-market.html http://www.transparencymarketresearch.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market.html http://www.transparencymarketresearch.com/asthma-and-copd-market.html The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the radiopharmaceuticals market as below: *Radiopharmaceuticals Market by Generator Types *Mo-99/Tc-99m generator *Sr-82/Rb-82 generator *Ge-68/Ga-68 generator *Sr-90/Y-90 generator *W-188/Re-188 generator *Radiopharmaceuticals Market by End-Users *Hospitals & Medical Centers *Diagnostic Centers *Radiopharmaceuticals Market by Applications *Diagnosis *Diagnosis by Technique *SPECT *Technetium (Tc-99m) *Thallium (TI-201) *Gallium (Ga-67) *Iodine (I-123) *Rhenium (Re-186) *Yttrium (Y-90) *Others *PET *Fludeoxyglucose (18F-FDG) *Rubidium (Rb-82) *Others (Carbon-11 choline, Nitrogen-13 ammonia) *Diagnosis by Indications *Oncology *Cardiovascular *Others (Neurological, Thyroid, Gastrointestinal) *Therapy *Systemic Oncology *Iodine (I-131) *Yttrium (90Y) *Samarium (Sm-153) *Strontium (89Sr) *Rhenium (186Re) *Lutetium (Lu-177) *Erbium (169Er) *Others *Others (Cardiology, Neurology) *Radiopharmaceuticals Market by Geography *North America *Europe *Asia-Pacific *Rest of the World (RoW) Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html Upcoming Reports in Pharmaceutical Market Cell Based Assays Market Drug Discovery Technologies Market Sample Preparation In Genomics Antibody Drugs Market Treatments for Neurodegenerative Disorders Polymerase Chain Reaction (PCR) Technologies Radiopharmaceuticals Market Preventive Healthcare Technologies, Products & Services Market Kinase Inhibitors Market Heparin Market Theranostics Market About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with a highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Sheela AK 90 Sate Street, Suite 700Albany, NY 12207 Tel: +1-518-618-1030USA - Canada Toll Free: +1-866-552-3453 Email: firstname.lastname@example.org Visit: http://de.transparencymarketresearch.com/ Visit: http://www.transparencymarketresearch.com/
Global Radiopharmaceuticals Market Is Expected to Reach USD 12.2 Billion in 2018: Transparency Market Research
Press spacebar to pause and continue. Press esc to stop.